Clinical Trial Update: New Hemolysis Parameters in Sickle Cell Disease

View source ↗

Summary

This clinical trial update discusses the exploration of new hemolysis parameters in sickle cell disease. The trial status is listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Queen Fabiola Children's University Hospital | Conditions: Sickle Cell Disease | Status: UNKNOWN